Visualize PIM-1 Protein Function and Its Interaction With PI3K/Akt/mTOR Pathway Regulated by Its Active Sites Through

Na Li1,2,3, Youyi Zhao4, Danbo Wang1

  • 1Cancer Hospital of Dalian University of Technology, Shenyang, China.

Biotechnology Journal
|December 18, 2024
PubMed

Insights

Investigating active sites in PIM-1 kinase reveals Lys67 regulates substrate binding and PI3K/Akt/mTOR signaling. Pro81/Asn82 are crucial for ATP binding, while Asp167 has minimal impact on kinase activity.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Biochemistry

Background:

  • The Moloney Murine Leukemia virus 1 (PIM-1) kinase is implicated in numerous biological processes and diseases.
  • Understanding PIM-1's active sites is crucial for elucidating its function, but in vivo studies are limited.

Purpose of the Study:

  • To visualize and delineate the roles of specific active sites within PIM-1 kinase in live cells.
  • To investigate the relationship between PIM-1 active site function and the PI3K/Akt/mTOR signaling pathway.

Main Methods:

  • Development and application of three mutant EPHY probes using fluorescence resonance energy transfer (FRET) technology.
  • Transfection of mutant probes into cells, followed by treatment with PIM-1 inhibitors, ATP, and PI3K inhibitors.

Main Results:

  • Lys67 mutation affects substrate binding and catalytic activity, directly impacting the PI3K/Akt/mTOR pathway.
  • Pro81/Asn82 mutations primarily affect ATP binding, modulating the PI3K/Akt/mTOR pathway with less impact on substrate interaction.
  • Asp167 mutation significantly inhibits substrate binding but has minimal effect on catalytic activity or the PI3K/Akt/mTOR pathway.

Conclusions:

  • Mutant probes serve as effective tools for visualizing PIM-1 active site functions in living cells.
  • Findings clarify PIM-1's molecular mechanisms and offer insights for PIM-1 targeted drug development and disease therapy.